Real-World Use and Impact of VMAT2 Inhibitors in Patients with Tardive Dyskinesia

被引：0
|
作者：
Lundt, L. [1 ]
Franey, E. [1 ]
Yonan, C. [1 ]
机构：
[1] Neurocrine Biosci Inc, San Diego, CA USA
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
102
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [41] Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Solmi, Marco
    Pigato, Giorgio
    Kane, John M.
    Correll, Christoph U.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1215 - 1238
  • [42] Real-world impact
    Seijo, Bibiana Campos
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (18) : 2 - 2
  • [43] Tardive dyskinesia in 2 patients treated with ziprasidone
    Ananth, J
    Burgoyne, KS
    Niz, D
    Smith, M
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2004, 29 (06): : 467 - 469
  • [44] Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia
    Goldberg, E.
    Yonan, C.
    Longo, N.
    Cratty, H.
    Nicosia, M.
    Sampalis, J.
    Carmack, T.
    Siegert, S.
    Angelov, A.
    MOVEMENT DISORDERS, 2020, 35 : S39 - S39
  • [45] REAL-WORLD EVALUATION OF PATIENT CHARACTERISTICS AND DISEASE MANAGEMENT IN LONG-TERM VALBENAZINE TREATMENT IN ADULTS WITH TARDIVE DYSKINESIA
    Siegert, S.
    Yonan, C.
    Longo, N.
    Cratty, H.
    Nicosia, M.
    Sampalis, J.
    Carmack, T.
    Dhanda, R.
    Farahmand, K.
    Lundt, L.
    Angelov, A.
    Goldberg, E.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E117 - E118
  • [46] REAL-WORLD INCIDENCE AND IMPACT OF PNEUMONITIS IN LUNG CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Tiu, Bruce
    Zubiri, Leyre
    Iheke, James
    Pahalyants, Vartan
    Theodosakis, Nicholas
    Ugwu-Dike, Pearl
    Seo, Jayhyun
    Tang, Kimberly
    Sullivan, Ryan
    Mooradian, Meghan
    Semenov, Yevgeniy
    Reynolds, Kerry
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A841 - A841
  • [47] Use of RET inhibitors among patients with advanced NSCLC: A real-world evidence analysis.
    Dawood, Shaheenah S.
    Brzozowski, Kaylen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study
    Cutler, Andrew J.
    Caroff, Stanley N.
    Tanner, Caroline M.
    Shalhoub, Huda
    Lenderking, William R.
    Page, Veronique
    Franey, Ericha
    Yonan, Chuck
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2023, 29 (05) : 389 - 399
  • [49] Discovery of VMAT2 modulators as potential treatments for methamphetamine use disorders
    Zheng, Guangrong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [50] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
12345